Pharma Journalist 7836 posts 0 comments

Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, signed a Memorandum of Understanding (MoU) with National Institute of Cholera and Enteric Diseases…
Read More...

Clinical-stage immuno-oncology firm Agenus is reorganizing its business and operations to straighten its focus on clinical development of its two checkpoint inhibitor antibodies and…
Read More...

Vanda Pharmaceuticals Inc. announced that it has entered into a license agreement with UC San Francisco (UCSF), under which Vanda will acquire an exclusive worldwide license from UCSF…
Read More...

Sonoma Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced…
Read More...

Mylan N.V., today announced the successful acquisition of the global rights to the Cold-EEZE brand cold remedy line from ProPhase Labs, Inc. The transaction provides Mylan all assets…
Read More...

Mylan announced the successful acquisition of the global rights to the Cold-EEZE brand cold remedy line from ProPhase Labs, Inc. The transaction provides Mylan all assets and rights…
Read More...

Sonoma Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced…
Read More...

Mylan N.V., today announced the successful acquisition of the global rights to the Cold-EEZE brand cold remedy line from ProPhase Labs, Inc. The transaction provides Mylan all assets…
Read More...

Vanda Pharmaceuticals Inc. announced that it has entered into a license agreement with UC San Francisco (UCSF), under which Vanda will acquire an exclusive worldwide license from UCSF…
Read More...

Perrigo Company plc, a leading global provider of Quality Affordable Healthcare Products announced that it has completed the divestiture of its rights to the royalty stream from global…
Read More...